Assessment and pharmacotherapy of depression.
Depressive disorders are experienced by a significant number of patients with cancer, with reported rates of 0%-58% (Massie, 2004). Numerous studies have demonstrated that depression in patients with cancer is underdiagnosed and inadequately treated as a result of a number of factors (Schwartz, Lander, & Chochinov, 2002). Although more severe or complex situations involving depression or other mental illness necessitate specialist referral, sometimes professionals treating patients with cancer may find the need to initiate treatment. Thus, clinicians need to be aware of basic principles related to the assessment and treatment of depression.
Van Fleet
Sharon
S
H. Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, USA. vanflesk@moffitt.usf.edu
D000928:Antidepressive Agents / Q000627:therapeutic use; D003866:Depressive Disorder / Q000175:diagnosis* / Q000188:drug therapy* / Q000209:etiology / Q000523:psychology; D006801:Humans; D010353:Patient Education as Topic; D012017:Referral and Consultation
D000928:Antidepressive Agents